UK markets close in 6 hours 49 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
71.27+2.63 (+3.83%)
At close: 04:00PM EDT
72.00 +0.73 (+1.02%)
After hours: 06:54PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close68.64
Open69.26
Bid70.99 x 100
Ask71.31 x 100
Day's range68.80 - 71.85
52-week range49.24 - 94.57
Volume186,008
Avg. volume157,495
Market cap1.262B
Beta (5Y monthly)0.93
PE ratio (TTM)23.52
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date02 Jul 2010
1y target estN/A
  • Business Wire

    Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference

    SAN DIEGO, March 05, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference in Miami on Thursday, March 14, 2024, at 10:45 a.m. Eastern Time.

  • Business Wire

    Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SAN DIEGO, March 04, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that effective March 1, 2024, Ligand’s Human Capital Management and Compensation Committee approved the grant of a non-qualified stock option award to purchase 15,100 shares of its common stock to one non-executive employee. The grant date for the options was March 1, 2024.

  • Business Wire

    Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

    SAN DIEGO, February 27, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended December 31, 2023, and provided an operating forecast and business updates. Ligand management will host a conference call and webcast today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions.